Credit: Healthware International
While the FDA was giving greenlight to the first digital ingestion tracking system, paving the way to a new dimension in digital therapies, people coming from all around the world came together in Berlin to debate the potential in digital health in the framework of Frontiers Health Conference, at the spectacular AXICA convention center.
More than 400 international experts, professionals, innovators, managers, startuppers, and investors met up to build the digital future of healthcare.
Frontiers Health took place in Berlin November 16-17, 2017 and gathered professionals from pharma, VC, startups, and insurance companies who shared their visions, ideas and experiences about the healthcare of tomorrow (but definitely starting today!). It’s so evident that the dynamics undergoing and boosting the revolution in this field are characterized by being collaborative and flexible, and that the increasing and seamless integration between medicine and technology is going to replace the traditional methods for improving health.
New trends in medicine
"Where healthcare meets innovation" is the motto adopted for the second edition of the conference. We all can’t disagree since the age of healthcare convergence is contributing to bringing two strategic sectors, like medicine and technology closer, by creating new opportunities and emerging trends, such as health-driven technologies, digital therapies, and health insurance.
A special platform
Roberto Ascione, CEO of Healthware International and Frontiers Health Conference Chairman, affirms that “the conference is one of the most relevant international initiative dedicated to digital health, thanks to the heterogeneity of its panelists and attendees, providing a unique platform of debate on the convergence of innovations in different fields, completely reshaping the future of healthcare".
Role of the digital therapies
Digital therapies is one of the key topics addressed, with more than 30 firms operating in this sector. A panel session was dedicated to the newly established Digital Therapeutics Alliance (DTA) whose members (Pierre Leurent, CEO Voluntis, Anand Lyer, Chief Strategy Officer WellDoc, and Vincent Hennemand, VP of Strategy, Corporate & BD Akili Interactive) illustrated the ongoing changes, the opportunities for the healthcare providers and the pharma industry, and the commitment in defining therapy protocols and clinically proved data.
You can find the full article here.
This article was written by Luigi Pavia from Campania Bioscience.